INCREASED EXPRESSION OF T-CELL-ASSOCIATED GENES IN BASELINE BIOPSIES FROM TNF ANTAGONIST NAIVE PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS WHO UNDERGO REMISSION IN RESPONSE TO ETROLIZUMAB IN A PHASE II TRIAL

(1) Genentech Research And Early Development, South San Francisco, United States

(2) Genentech Research And Early Development, San Francisco, Ca, United States

(3) King's College London, London, United Kingdom

(4) University Of Newcastle, Newcastle Upon Tyne, United Kingdom

(5) University Of Leuven, Leuven, Belgium

(6) University Of Western Ontario, Ontario, Canada

(7) Hospital Clinic Barcelona, Barcelona, Spain

(8) Humboldt-University Of Berlin, Berlin, Germany

(9) Christian Albrechts University, Kiel, Germany

(10) Tel Aviv University, Tel Aviv, Israel

(11) University Of California, San Diego, United States



This item was part of UEG Week 2014

This item can be cited as: United European Gastroenterology Journal; 2014: 2 (Supplement 1)